Lasting immune memory against hepatitis B following challenge 10–11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11–12 months of age - Avdicova, Mária; Crasta, Priya D.; Hardt, Karin; Kovac, Martina (Vaccine, 2015)
Keywords: Age; Age Factors; Allergy and Immunology; antibodies; blood sampling; Child; children; Chronic illnesses; Confidence intervals; Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage; Diphtheria-Tetanus-Pertussis Vaccine - immunology; DTPa-HBV-IPV/Hib; Female; Haemophilus influenzae; Haemophilus Vaccines - administration & dosage; Haemophilus Vaccines - immunology; Hepatitis; Hepatitis B; Hepatitis B - prevention & control; Hepatitis B Antibodies - blood; Hepatitis B Vaccines - administration & dosage; Hepatitis B Vaccines - immunology; Hepatitis B virus; Hepatitis B virus - immunology; Humans; Immune memory; Immunologic Memory; Infant; Infections; Male; Persistence; Poliovirus; Poliovirus Vaccine, Inactivated - administration & dosage; Poliovirus Vaccine, Inactivated - immunology; Public health; seroprevalence; vaccination; Vaccination - methods; Vaccine; Vaccines; Vaccines, Combined - administration & dosage; Vaccines, Combined - immunology; anti-HBs; CI; Immune memory; HBsAg; Vaccine; Persistence; SD; SAE; DTPa-HBV-IPV/Hib; DTPa-IPV/Hib; GMC; ATP; HBV; CLIA; WHO; Hepatitis B; geometric mean antibody concentration; hepatitis B virus; according to protocol; serious adverse event; hexavalent diphtheria–tetanus–pertussis–hepatitis B-inactivated poliomyelitis and Haemophilus influenzae type b conjugate vaccine; World Health Organization; hepatitis B surface antigen; antibody against hepatitis B surface antigen; diphtheria–tetanus–pertussis-B-inactivated poliomyelitis and Haemophilus influenzae type b conjugate vaccine; confidence interval; chemiluminescence immunoassay; standard deviation